#gforce-pd

[pknoepfl]

Hope on Parkinson's front: Japan IPSC trial 1st patient

Hope on Parkinson’s front: Japan IPSC trial 1st patient

In Parkinson’s Disease patients develop neurological dysfunction as they lose a special kind of brain cell called dopaminergic (or dopamine) neurons. While a number of different approaches to this disease have been studied for decades, nothing has proven particularly successful in slowing its progression. As a result there has been a big need for novel thinking about how to tackle Parkinson’s…

View On WordPress

[pknoepfl]

On the threshold of cell therapy for Parkinson’s disease

On the threshold of cell therapy for Parkinson’s disease

By Jeanne Loring

Dopamine neurons derived from a Parkinson’s disease patient’s iPSCs (Tyrosine hydroxylase). Image source: Loring lab.

There are ten million people in the world who have Parkinson’s disease. 125,000 of these are living in California.  People with the disease often have to step away from their jobs because the main symptoms – tremor or freezing up of muscles – make it difficult to…

View On WordPress